策划“自问自答”构成误导性陈述，英集芯被证监会立案调查

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Shenzhen Yingjixin Technology Co., Ltd. for alleged misleading statements in information disclosure related to its products and market positioning in the brain-computer interface sector [2][5]. Group 1: Investigation Details - On February 13, the CSRC announced the investigation into Yingjixin for potential violations of information disclosure laws [2]. - The investigation stems from an incident on January 6, 2026, where Yingjixin engaged in a "self Q&A" on the Shanghai Stock Exchange's E-interaction platform, which was deemed misleading [5]. - The CSRC's decision to investigate is based on the provisions of the Securities Law and the Administrative Penalty Law of the People's Republic of China [5]. Group 2: Company Response and Product Information - Yingjixin acknowledged receipt of the CSRC's notice and stated that it is committed to addressing the issues raised [5]. - The company claimed to have made early investments in the brain-computer interface chip sector, specifically mentioning the IPA1299 chip, which is designed for high-precision measurement of biological electrical signals [5]. - The IPA1299 chip has reportedly been mass-produced and is said to have performance parameters comparable to leading international products in the same category [5]. Group 3: Regulatory Concerns - The Shanghai Stock Exchange issued a regulatory warning to Yingjixin and its responsible parties, emphasizing the need for accurate and cautious information disclosure, especially given the heightened market interest in brain-computer interface concepts [5]. - The exchange pointed out that the company's responses on the E-interaction platform did not accurately reflect the product's launch entity, sales scale, and international product path differences, and failed to adequately disclose uncertainties regarding future sales [6].